Dishman Pharma confident of meeting revenue guidance: CMD

The company is on track to meet their revenue guidance for the year, said JR Vyas, CMD of Dishman Pharma.

JR Vyas, CMD of  Dishman Pharma in an interview to CNBC-TV18 spoke about the outlook for the company going forward. The company is on track to meet their revenue guidance for the year and is targeting a debt reduction of Rs 100 cr in FY16 via cash accruals.

Dishman Pharma stock price

On March 13, 2015, Dishman Pharmaceuticals & Chemicals closed at Rs 171.45, down Rs 2.8, or 1.61 percent. The 52-week high of the share was Rs 197.00 and the 52-week low was Rs 85.30.

The company's trailing 12-month (TTM) EPS was at Rs 12.99 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 13.2. The latest book value of the company is Rs 98.77 per share. At current value, the price-to-book value of the company is 1.74.

Anda sedang membaca artikel tentang

Dishman Pharma confident of meeting revenue guidance: CMD

Dengan url

http://kebugaranhidup.blogspot.com/2015/03/dishman-pharma-confident-of-meeting.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Dishman Pharma confident of meeting revenue guidance: CMD

namun jangan lupa untuk meletakkan link

Dishman Pharma confident of meeting revenue guidance: CMD

sebagai sumbernya